How Cancer Centers Lie About the Definition of Palliative Care

Executive Summary Palliative care has a specific and accurate definition. When cancer centers found that this definition reduced their ability to sell treatment, they began writing articles to try to muddy the water on what palliative care actually is. Introduction Cancer centers and oncologists make a great deal of money from palliative care. However, the…

What Does the Term Response Rate Mean When it Comes to Cancer Treatment?

Executive Summary The term response rate is used in cancer research studies and articles on cancer treatments. In this article, we explain what this term means. Introduction Articles on cancer will frequently use the term “response rate”; however, they usually do so without defining the term. Part of the problem in interpreting the effectiveness of…

How Immunotherapy is Used as a Way to Get More Revenues From Patients at End of Life

Executive Summary When patients have been subjected to ineffective cancer treatments, often the final treatment recommended is immunotherapy. Rather than being an effective treatment, it is usually recommended to allow the cancer center to perform more billing to the insurance company. Introduction Immunotherapy benefits from being less well understood by patients than either radiotherapy or…

How The Side Effects of Immunotherapy Are Minimized by the Medical Establishment

Executive Summary The side effects of immunotherapy are shocking. In this article, we discuss what the articles that cover immunotherapy on sites that promote the topic do not cover. Introduction It is impossible to get an accurate understanding of the side effects of immunotherapy from the generally available top websites that cover the topic. This…

Hyperprogression: How Immunotherapy Frequently Leads to Worsening Cancer

Executive Summary Immunotherapy often worsens cancer and further weakens the patient. In this article, we discuss what the articles that cover immunotherapy on sites that promote the topic do not cover. Introduction A significant side effect of immunotherapy is called hyperprogression, or HPD. Hyperprogression is where the immunotherapy drug worsens the impact of cancer that…

Breast Cancer Patients Are Still Not Getting Shorter Chemotherapy Treatment

Executive Summary While there is ample evidence for breast cancer patients to get less chemotherapy, patients are still getting too lengthy treatments. Introduction In a previous article titled How The Medical Establishment Hides Their Error With Chemotherapy for Breast Cancer, several articles claimed that chemotherapy had become much more targeted due to genetic testing. Wait…

How Effective is Precision or Targeted Cancer Treatment?

Executive Summary Many cancer centers promote the benefits of prediction oncology. This article covers the reality of the effectiveness of precision oncology or precision cancer treatment. Introduction It is very common for cancer centers and oncologists to promote precision or targeted cancer treatment. In this article, we present the actual expected effects of these items….

|

What is the Difference Between the Purchase Unit and Dosage for Ivermectin?

Executive Summary When applying an Ivermectin dosage, there can be the question of the relationship between the purchasing unit and the dosage. Introduction The purchasing unit of a drug is different than the dosage. And the two also are important when considering which purchasing unit to buy. Wait One Second… Why is The Article Not…

How Patients and Oncologists Engage in Mutual Delusion on Cancer Mortality and Life Expectancy

Executive Summary One of the little-discussed topics of oncology is how both oncologists and patients do not address the issue of life expectancy as part of the cancer prognosis. Introduction One of the significant areas not covered by the establishment media or any medical entity is that cancer patients have a highly inaccurate understanding of…